Is Osteopontin a Reliable Biomarker for Endometriosis?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211857 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aleksandra Zygula und 9 weiteren Autor:innen. Beteiligte Einrichtung: OVIklinika Infertility Center, 01-377 Warsaw, Poland. Hauptthemen laut MEDLINE: Endometriosis, Osteopontin, Biomarkers, Ascitic Fluid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Polish Ministry of Health; the international project acronym TRENDO, co-funded by the funds of the Ministry of Science and Higher Education program entitle…, Polish Ministry of Health, TRENDO.
Abstract (Originalsprache)
This study aimed to evaluate the concentration of osteopontin in peritoneal fluid and plasma as potential biomarkers for diagnosing endometriosis. Osteopontin levels were measured using surface plasmon resonance imaging (SPRI) biosensors in patients suspected of having endometriosis. Plasma samples were collected from 120 patients, and peritoneal fluid was collected from 86 patients. Based on the detection of endometriosis lesions during laparoscopy, participants were divided into a study group (patients with endometriosis) and a control group (patients without endometriosis). The results showed no significant differences in plasma osteopontin levels between women with endometriosis and the control group (19.86 ± 6.72 ng/mL vs. 18.39 ± 4.46 ng/mL, p = 0.15). Similarly, peritoneal fluid osteopontin concentrations did not differ significantly between patients with and without endometriosis (19.04 ± 5.37 ng/mL vs. 17.87 ± 5.13 ng/mL, p = 0.29). Furthermore, osteopontin levels in both plasma and peritoneal fluid were not significantly associated with the stage of endometriosis, the presence of endometrioma, or the menstrual cycle phase. The findings of this study do not support osteopontin concentration as a reliable biomarker for endometriosis. However, further research is necessary to explore osteopontin’s potential role in the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- OVIklinika Infertility Center, 01-377 Warsaw, Poland.
- Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland.
- Angelius Provita Hospital, 40-611 Katowice, Poland.
- Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, 15-328 Bialystok, Poland.
- Department of Gynecology and Gynecological Oncology, Medical University of Bialystok, 15-089 Bialystok, Poland.
- Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, 00-189 Warsaw, Poland.
ORCID-Profile: Michal Ciebiera, Tadeusz Issat
Förderung
- the Polish Ministry of Health; the international project acronym TRENDO, co-funded by the funds of the Ministry of Science and Higher Education program entitle…
- Polish Ministry of Health
- TRENDO
- Ministry of Science and Higher Education program
Zitieren
APA
Zygula, A., Kiecka, K., Sankiewicz, A., Kuzmicki, M., Ciebiera, M., Issat, T., Drygas, W., Cendrowski, K., Gorodkiewicz, E., & Laudanski, P. (2024). Is Osteopontin a Reliable Biomarker for Endometriosis?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211857
Vancouver
Zygula A, Kiecka K, Sankiewicz A, Kuzmicki M, Ciebiera M, Issat T, et al. Is Osteopontin a Reliable Biomarker for Endometriosis?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211857
BibTeX
@article{Zygula2024,
author = {Zygula, Aleksandra and Kiecka, Kamil and Sankiewicz, Anna and Kuzmicki, Mariusz and Ciebiera, Michal and Issat, Tadeusz and Drygas, Wojciech and Cendrowski, Krzysztof and Gorodkiewicz, Ewa and Laudanski, Piotr},
title = {Is Osteopontin a Reliable Biomarker for Endometriosis?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211857}
}
EUVIMED